VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
HNGEHinge Health, Inc.$65.34$5.1B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksHNGERevenue History

HNGE logoHinge Health, Inc. (HNGE) Revenue History

Annual and quarterly revenue from 2023 to present

TTM Revenue$646.3M▲ +$58.5M vs FY2025
YoY Growth+47.2%Excellent
Q1 2026$182.3M+47.2% YoY · +6.8% QoQ
Revenue CAGR
3Y—
→
5Y—
→
10Y—
Best Fiscal Year$587.9M (2025)
Best Quarter$182.3M (Q1 2026)
Revenue per Share$8.21
Revenue per Employee$427K

HNGE Revenue Over Time (2023–2025)

HNGE Revenue Growth History

2 of 2 years with positive growth
Annual Revenue Growth · Each cell = one fiscal year
2023—
2024+33.4%
2025+50.6%
FY2023 revenue growth
N/A
FY2024 revenue growth
+33.4%
FY2025 revenue growth
+50.6%
DeclineStrong growth
↑ 2-year growth streakBest: +50.6% (FY2025)Worst: +33.4% (FY2024)
Recent Quarterly Revenue & YoY Growth
QuarterRevenueYoY
Q1 2026$182.3M+47.2%
Q4 2025$170.7M+45.6%
Q3 2025$154.2M—
Q2 2025$139.1M—
Q1 2025$123.8M+49.7%
Q4 2024$117.3M—
Q1 2024$82.7M—
Seasonal Revenue Pattern (fiscal quarters)
Q1
21%
Q2
24%
Q3
26%
Q4
29%

Multi-year avg. share of annual revenue by fiscal quarter

Revenue Breakdown (FY 2025)

HNGE's revenue distribution by segment and geography for fiscal year 2025

By Product/Segment

Reportable Segment100.0%

HNGE Revenue Analysis (2023–2025)

Current Revenue & Growth

As of June 13, 2026, Hinge Health, Inc. (HNGE) generated trailing twelve-month (TTM) revenue of $646.3 million, reflecting explosive growth of +47.2% year-over-year. The most recent quarter (Q1 2026) recorded $182.3 million in revenue, up 6.8% sequentially.

Historical Growth Trajectory

HNGE's historical revenue data shows various trends over time. Hinge Health, Inc.'s highest annual revenue of $587.9 million was recorded in 2025, an all-time high.

Revenue by Segment

HNGE's revenue is primarily driven by Reportable Segment (100%). With over half of revenue concentrated in Reportable Segment, the company has a focused business model while developing other growth vectors.

Peer Comparison

Compared to Healthcare sector peers — including OMCL (+7.9% YoY), TDOC (-1.5% YoY), and HIMS (+32.8% YoY) — HNGE has outperformed the peer group in revenue growth. Compare HNGE vs OMCL →

HNGE Revenue vs Peers

Revenue metrics vs comparable public companies

CompanyTTM RevenueYoY Growth5Y CAGROp. MarginCompare
HNGE logoHNGECurrent$646M+47.2%--92.9%
OMCL logoOMCL$1.2B+7.9%+5.8%0.4%
TDOC logoTDOC$2.5B-1.5%+18.3%-10.4%
HIMS logoHIMS$2.3B+32.8%+73.6%4.5%
DOCS logoDOCS$645M+13.1%+25.5%33.3%
AMWL logoAMWL$249M-30.3%+0.3%-42.2%
Best in groupLowest in group

HNGE Historical Revenue Data (2023–2025)

1–3 of 3 records
Year Revenue YoY % Gross Profit Gross Margin Op. Income Op. Margin
2025$587.9M+50.6%$468.2M79.6%$-546,371,000-92.9%
2024$390.4M+33.4%$300.6M77.0%$-24,429,000-6.3%
2023$292.7M-$194.2M66.3%$-130,514,000-44.6%

What if you invested $1,000 in HNGE back in 2023?

Total return with dividends reinvested · 3+ years of data

Calculate Returns

How much would $100/month in HNGE be worth today?

Dollar cost averaging vs lump sum · see how regular investing compounds over time

Run the Numbers

Is HNGE Undervalued Right Now?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

HNGE vs LLY — which is the better buy?

Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.

Compare Now

HNGE — Frequently Asked Questions

Quick answers to the most common questions about buying HNGE stock.

Is HNGE's revenue growth accelerating or slowing?

HNGE revenue growth is accelerating. TTM revenue reached $646M, up +47.2% year-over-year — ahead of the 5-year CAGR of N/A. This indicates the business is expanding faster than its historical baseline.

What is HNGE's revenue history from 2023 to 2026?

Hinge Health, Inc. (HNGE) revenue history spans 2023 to 2026. TTM revenue as of 2026 is $646M, growing at +47.2% YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.

What is HNGE's long-term revenue growth rate (CAGR)?

Hinge Health, Inc.'s 5-year revenue CAGR of N/A reflects the sustained nature of its business expansion. As of 2026, the current YoY growth rate of +47.2% is above this long-term average. CAGR is the most reliable measure of sustained revenue momentum for HNGE.

Why does HNGE's quarterly revenue fluctuate?

HNGE quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Hinge Health, Inc.'s revenue data from 2023 to 2026 shows full historical quarterly detail on this page.

How is HNGE's revenue distributed by segment?

HNGE reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.

How does HNGE's revenue compare to industry peers?

Hinge Health, Inc. (HNGE) with TTM revenue of $646M and +47.2% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.